Future Tech
Presently, finding effective ways to reutilize these space-occupying, stored CO2 has become an urgent priority. High performance electrochemical CO2 converter is found to be an auspicious resolution for transforming CO2 into valuable chemicals (formic acid, CO, C2H4, ethanol, etc.), providing numerous benefits, including high conversion efficiency, low energy consumption, and also the potential for integration with renewable energy sources, enabling the realization carbon-negative goals.
Future Tech | Green Energy ＆ Environment
- Voltraware’s core technology is based on Magnetic Resonance (MR), which enables wireless charging of multiple devices from a distance without precise alignment. - MR technology minimizes heating effects on metal objects, ensuring safe and effective operation. - Utilizes advanced engineering to deliver efficient wireless power transmission at 6.78MHz through a transmitter and receiver coil system. - VW8000 IC features integrated Foreign Object Detection (FOD), real-time condition monitoring, auto-regulation of power delivery, and advanced PWM engines. - Voltraware provides a one-stop wireless charging solution, covering from ASIC, coil and system design, firmware, and automated control.
Future Tech | Green Energy ＆ Environment/Life Application
Our team developed a TCN model using publicly available ICU datasets and externally validated it by data from NTUH. The results show that TCN can predict over 90% of sudden cardiac arrest cases six hours before the cardiac arrest events, with an AUC of 0.96, outperforming NEWS, which has an AUC of 0.87 and a sensitivity of 81% six hours before cardiac arrest occurs. Furthermore, we utilized generative AI to predict vitals of the next hour based on patient past vital signs and medical records.
Future Tech | Information ＆ Communications
Establish human gut ecosystem simulator for dynamically culturing gut microbiome. Probiotic extracellular vesicles (EV) are used as natural nanocarrier to target pathogen and deliver specific RNAs to treat infection. EV target different tissues after oral administration, effectively inhibiting C. difficile proliferation and virulence without affecting other gut microbiota. The method offers high safety, low cost, high yield, and net-zero emissions, demonstrating significant commercial potential.
Future Tech | Biotechnology ＆ Medical careComing soon!
